Johnson & Johnson And Novavax Vaccines May Not Sustain Herd Immunity Against Coronavirus Variants, New Trial Results Reveal

Johnson & Johnson's vaccine is being developed under the leadership of the subsidiary Janssen Vaccines in Leiden, The Netherlands.

While the trials show solid protection against the original strain, both struggled to contain the South African variant, suggesting the time is ticking on their usefulness. [ more › ]